VivoSim Labs
VIVS
100 hedge funds and large institutions have $102M invested in VivoSim Labs in 2014 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 29 reducing their positions, and 27 closing their positions.
0.09% more ownership
Funds ownership: 0% → 0.09% (+0.09%)
3% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 29
13% less funds holding
Funds holding: 115 → 100 (-15)
23% less capital invested
Capital invested by funds: $133M → $102M (-$30.6M)
23% less call options, than puts
Call options by funds: $6.96M | Put options by funds: $9.05M
56% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$4.13M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.93M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.81M |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$663K |
| 5 |
Bank of New York Mellon
New York
|
+$299K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$2.94M |
| 2 |
U
UBS
Zurich,
Switzerland
|
-$2.15M |
| 3 |
D.E. Shaw & Co
New York
|
-$621K |
| 4 |
BL
Bolton LP
Greenwich,
Connecticut
|
-$616K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$522K |
VIVS Hedge Fund Activity: Q3 2014 in Review
100 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q3 2014, worth a combined $102M — down 23% from $133M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of VIVS and 12 opened new positions — a net loss of 15 holders — while 29 trimmed existing stakes and 28 added.
The largest buyer was Northern Trust, adding an estimated $4.13M. The largest seller was Goldman Sachs, cutting an estimated $2.94M.
- 100 institutional investors held VivoSim Labs (VIVS) as of Q3 2014, down from 115 in Q2 2014.
- Funds reported $102M of VivoSim Labs stock for Q3 2014, down 23% quarter-over-quarter.
- 12 funds opened new VivoSim Labs positions in Q3 2014 and 27 closed out, a net change of -15 holders.
- The largest VivoSim Labs buyer in Q3 2014 was Northern Trust, an estimated $4.13M added.
- The largest VivoSim Labs seller in Q3 2014 was Goldman Sachs, an estimated $2.94M sold.
Based on aggregated 13F filings for Q3 2014.